Shield Therapeutics plc Cash Flow Reinvestment Rate
Latest as of June 2020:
0.00x
Shield Therapeutics plc cash flow reinvestment rate. Shield Therapeutics plc (STX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting GBX2.00K (capex GBX2.00K ) from operating cash flow of GBX2.40 Million. Explore STX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
GBX2.00K
Capex + Investments
Operating Cash Flow
GBX2.40 Million
GBX
Capital Expenditures
GBX2.00K
GBX
Shield Therapeutics plc Cash Flow Reinvestment Rate by Year (None–None)
Shield Therapeutics plc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Shield Therapeutics plc. For the full cash flow conversion analysis, see how efficiently does Shield Therapeutics plc generate cash.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow